Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic…more
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic…more
Latest RNS from Convatec Group PLC
- buybackTransaction in Own Shares
- holdingsHolding(s) in Company
- tvrTotal Voting Rights
- holdingsHolding(s) in Company
- buybackTransaction in Own Shares
Analyst consensus: Buy
As of 6 Oct 2026, 19 analysts rate Convatec Group PLC a Buy, with 95% buy ratings and a mean price target of 305p (range 230p–374p), +38% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 210p against a current price of 219p (-4%), based on EV/EBITDA.